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Abstract. 
 
We show that normal peripheral nerve my-
elination depends on strict dosage of the most abun-
dantly expressed myelin gene, 
 
myelin protein zero
 
 
(
 
Mpz
 
). Transgenic mice containing extra copies of 
 
Mpz
 
 
manifested a dose-dependent, dysmyelinating neuropa-
thy, ranging from transient perinatal hypomyelination 
to arrested myelination and impaired sorting of axons 
by Schwann cells. Myelination was restored by breeding 
the transgene into the 
 
Mpz
 
-null background, demon-
strating that dysmyelination does not result from a 
structural alteration or Schwann cell-extrinsic effect of 
the transgenic P
 
0 
 
glycoprotein. 
 
Mpz
 
 mRNA overex-
pression ranged from 30–700%, whereas an increased 
level of P
 
0
 
 protein was detected only in nerves of low 
copy-number animals. Breeding experiments placed the 
threshold for dysmyelination between 30 and 80% 
 
Mpz
 
 
overexpression. These data reveal new points in nerve 
development at which Schwann cells are susceptible to 
increased gene dosage, and suggest a novel basis for he-
reditary neuropathy.
Key words: axon sorting • myelin • neuropathy • 
Schwann cell • transgene
 
Introduction
 
The myelin sheath displays a unique molecular architec-
ture that depends on precisely regulated protein synthesis
and trafficking. First, myelinating glia, Schwann cells in
peripheral nerve, and oligodendrocytes in brain and spinal
cord, must solve a remarkable problem of quantity: to pro-
duce as much as three times their weight in proteins and
lipids per day of myelinogenesis (Norton and Poduslo,
1973). Coordinate synthesis of myelin proteins is in part
transcriptionally mediated, as high-level transcription of
the genes encoding myelin-specific proteins is induced si-
multaneously during myelinogenesis (Stahl et al., 1990;
Scherer et al., 1994; Wrabetz et al., 1998). Second, the traf-
ficking of these mRNAs and proteins is carefully regu-
lated. For example, in myelin-forming Schwann cells, P
 
0
 
glycoprotein (P
 
0
 
)
 
1
 
 is synthesized in the RER, and traf-
ficked via the Golgi apparatus specifically to the forming
myelin sheath (D’Urso et al., 1990; Trapp et al., 1995). In
contrast, the mRNA encoding myelin basic protein (MBP)
is trafficked to cytoplasmic spaces adjacent to the forming
myelin sheath, where MBP is synthesized on free ribo-
somes and rapidly incorporated into myelin (Colman et al.,
1982; Trapp et al., 1987; Griffiths et al., 1989).
It is not surprising, therefore, that both naturally occur-
ring and induced mutations reveal the importance of pre-
cisely regulated gene dosage for normal myelination. For
example, the gain or loss of only one allele of the proteo-
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Abbreviations used in this paper:
 
 
 
1
 
/
 
2
 
, heterozygous; CHN, congenital hy-
pomyelination neuropathy; CMAP, compound muscle action potential;
CMT1A, Charcot-Marie-Tooth 1A neuropathy; CNS, central nervous sys-
tem; F80, founder 80; GAPDH, glyceraldehyde-3-phosphate dehydroge-
nase; MBP, myelin basic protein; 
 
Mpz
 
, 
 
myelin protein zero
 
 gene; NCV,
nerve conduction velocity; nt, nucleotide; P, postnatal day; P
 
0
 
, P
 
0
 
 glyco-
protein; PLP, proteolipid protein; PMP22, peripheral myelin protein 22
kD; RT, reverse transcription; Tg80, transgenic line 80. 
The Journal of Cell Biology, Volume 148, 2000 1022
 
lipid protein gene (
 
PLP
 
), or peripheral myelin protein
22 kD gene (
 
PMP22
 
), produce central nervous system
(CNS) myelinopathies or demyelinating peripheral neurop-
athies in human (for reviews see Suter and Snipes, 1995;
Nave and Boespflug-Tanguy, 1996), and similar dosage al-
terations of 
 
Plp
 
 and 
 
Pmp22
 
 in transgenic rodents model
these diseases (
 
Plp
 
:
 
 
 
Boison and Stoffel, 1994; Kagawa et al.,
1994; Readhead et al., 1994; Klugmann et al., 1997; and
 
Pmp22
 
: Adlkofer et al., 1995; Magyar et al., 1996; Sereda
et al., 1996; Huxley et al., 1998). How altered PLP expres-
sion causes dysmyelination is unclear (for review see
Werner et al., 1998), but overexpressed PMP22 arrives to
the myelin sheath (Vallat et al., 1996), possibly destabiliz-
ing its formation or maintenance. The observation that
mutations in diverse myelin genes produce similar disease
phenotypes implies that various myelin proteins interact in
functional units. In keeping with this, physical interaction
between PMP22 and P
 
0
 
 has been detected in myelin
(D’Urso et al., 1999) supporting that multiprotein assem-
blies reside within the myelin sheath. Thus, destabilization
of myelin formation due to altered myelin gene dosage
may reflect a need for stringent stoichiometry during pro-
tein trafficking to, and assembly of, the myelin sheath.
P
 
0
 
 mRNA (
 
z
 
8% of total mRNA) and protein (
 
.
 
50% of
peripheral myelin protein; Greenfield et al., 1973) are by far
the most abundant in nerve. P
 
0
 
 is a single-pass transmem-
brane protein with an extracellular immunoglobulin-like
domain, and a cytoplasmic tail enriched in basic residues
(Lemke and Axel, 1985; Shapiro et al., 1996). The extra-
cellular domain of P
 
0
 
 participates in homophilic interac-
tions (D’Urso et al., 1990; Filbin et al., 1990; Schneider-
Schaulies et al., 1990; Shapiro et al., 1996), which mediate
compaction of the extracellular space between spirals of
Schwann cell plasma membrane during myelin formation,
as demonstrated by uncompaction of myelin in mice that
lack P
 
0
 
 (Giese et al., 1992). Phenotypes due to P
 
0
 
 overex-
pression have not been identified, but gene duplications
rather than nulls are increasingly appreciated as a mecha-
nism for genetic disease, especially for myelin genes. For
example, duplication of chromosomal segments contain-
ing 
 
PLP
 
 or 
 
PMP22
 
 cause Pelizeaus-Merzbacher Disease
(Nave and Boespflug-Tanguy, 1996) or Charcot-Marie-
Tooth 1A neuropathy (CMT1A; Suter and Snipes, 1995),
respectively.
Since P
 
0
 
 is the most abundant protein in peripheral my-
elin, and serves an analogous function to PLP in central
myelin, we sought to explore the phenotypic consequences
of overexpressing P
 
0
 
 using transgenic techniques. Our data
show that 
 
myelin protein zero
 
 (
 
Mpz
 
) gene dosage must be
precisely regulated, as overexpression of P
 
0
 
 causes a dose-
dependent, dysmyelinating neuropathy manifested by re-
markably delayed nerve development, including Schwann
cells that are unable to segregate axons. Thus far, we have
identified two possible pathogenetic mechanisms. First, in-
creasing P
 
0
 
 overexpression disregulates the stoichiometric
expression of other myelin genes. Second, P
 
0
 
 overexpres-
sion promotes inappropriate trafficking of P
 
0
 
 to Schwann
cell surface membranes (Yin et al., 2000, this issue). These
findings have implications for both coordinate expression
and trafficking of myelin proteins in developing nerve,
and for dosage dependent human neuropathies, such as
CMT1A.
 
Materials and Methods
 
Production of Transgenic Mice
 
Construction of the transgenic vector mP
 
0
 
TOTA has been described pre-
viously (Feltri et al., 1999). Like mP
 
0
 
TOTA, mP
 
0
 
TOT contains the com-
plete 
 
Mpz
 
 with 6 kb of promoter, all exons and introns, the natural poly-
adenylation site, and a polymorphic
 
 
 
BglII site in exon 3 (amino acid
sequence conserved) that is absent from the endogenous FVB/N 
 
Mpz
 
 al-
leles. In contrast to mP
 
0
 
TOTA, the ATG start site of translation of P
 
0
 
 re-
mains. For oocyte injection, the transgene monomer was excised from the
vector using XhoI and NotI.
Transgenic mice were obtained by standard techniques (Brinster et al.,
1985) using fertilized eggs obtained from the mating of FVB/N mice
(Taconic). Breeding lines of animals were maintained by backcrosses to
FVB/N mice (Taconic or Charles River). Ten founders were identified by
Southern blot and PCR analysis of genomic DNA prepared from tail sam-
ples (Sambrook et al., 1989). We documented expression in eight founders
or their progeny; these were further analyzed in this study. A 770-nucle-
otide (nt) BamHI
 
–
 
HindIII
 
 
 
restriction fragment from intron 1 of 
 
Mpz
 
 
 
was
used to generate a probe for Southern blot analysis of genomic DNA di-
gested with
 
 
 
BglII (Fig. 1). As endogenous and transgenic P
 
0
 
 alleles are
recognized identically by this probe, copy numbers were determined by
the quotient of the 2.8-kb divided by the 6.8-kb band intensity in Southern
blot analysis. The PCR primer sequences were: 5
 
9
 
-CCACCACCTCTC-
CATTGCAC-3
 
9
 
 and 5
 
9
 
-GGCGGATTGACCGTAATGGG-3
 
9
 
, and am-
plified a 540-nt fragment. BglII digestion of the product revealed addi-
tional fragments of 300 and 240 nt in transgenic samples (data not shown).
PCR conditions were: 94
 
8
 
C for 30 s, 57
 
8
 
C for 60 s, and 72
 
8
 
C for 60 s (25 cy-
cles), followed by 10 min extension at 72
 
8
 
C, in a standard PCR reaction
mix. The genetic designations of the three lines that have been maintained
Figure 1. Southern blot analysis for transgene copy number.
Southern blot analysis (B) revealed ten founders (F80), from
which three lines were established (Tg80). A polymorphic BglII
restriction site (B*) distinguishes the mP0TOT transgene from
the endogenous Mpz FVB/N alleles (A). Copy numbers (CN)
were estimated by the ratio of the 2.8–6.8-kb signal intensities. 
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from this study are transgenic lines: 80.2, TgN(Mpz)22Mes; 80.3, TgN
(Mpz)23Mes; and 80.4, TgN(Mpz)24Mes.
P
 
0
 
 heterozygous (
 
1
 
/
 
2
 
) null mice were backcrossed to FVB/N mice for
five generations and identified by PCR or Southern blot analysis of ge-
nomic DNA prepared from tail samples. The PCR primer sequences
were: 5
 
9
 
-TCAGTTCCTTGTCCCCCGCTCTC-3
 
9
 
 (forward, common), 5
 
9
 
-
GGCTGCAGGGTCGCTCGGTGTTC-3
 
9
 
 (reverse, neo) and 5
 
9
 
-ACT-
TGTCTCTTCTGGGTAATCAA-3
 
9
 
 (reverse, wild-type P
 
0
 
), and ampli-
fied a 500-nt fragment from a wild-type allele and a 334-nt fragment from
the null allele. Multiplex PCR conditions were 94
 
8
 
C for 60 s, 53
 
8
 
C for 180 s,
and 72
 
8
 
C for 180 s (40 cycles), followed by 10 min extension at 72
 
8
 
C, in a
standard PCR reaction mix.
Tg80.4 and P
 
0
 
1
 
/
 
2
 
 animals were crossed to generate breeders for the res-
cue experiments. Southern blot analysis as for Tg80 (above) distinguished
genotypes of offspring (see Fig. 8).
 
Behavioral Analysis
 
Tremor was estimated visually on a 
 
1
 
 to 
 
1111
 
 scale. Strength was mea-
sured in the forelimbs of adult mice using a Grip Strength Meter (Colum-
bus Instruments). In brief, mice were tested five consecutive times over a
span of about one min, recording peak force applied to the strain gauge
(in g). The maximum value achieved in the five tests was taken as an indi-
cation of strength and used for further calculations. To account for possi-
ble weakness due to muscle atrophy rather than strictly neural conduction
deficits, strength was expressed as a ratio of the maximal peak force over
body weight. The investigator performing the tests was blinded to the ge-
notype of each mouse. As grip strength/weight declined slightly with age
in normal controls, all reported measurements derive from littermates be-
tween postnatal day 90 (P90) and P110.
 
Electrophysiologic Analysis
 
Transgenic mice and control littermates at P42 were anesthetized by i.p.
injection of avertin, and the sciatic nerve and gastrocnemius muscle were
exposed and continuously perfused with Ringer’s solution at room tem-
perature. The compound muscle action potential (CMAP) was measured
extracellularly by a blunt tip glass pipette as the sciatic nerve was supra-
maximally stimulated with a bipolar stimulation electrode connected to a
Grass stimulator. To evaluate the nerve conduction velocity (NCV), the
nerve stimulation electrode was moved between two fixed sites on the
nerve separated by a known distance. The NCV was calculated as the dis-
tance divided by the time shift of the CMAP expressed in m/s. In parallel,
mice were killed by decapitation, and the sciatic nerves quickly excised
and placed in a nerve chamber at a bath temperature of 20
 
8
 
C. The com-
pound nerve action potential was recorded by a tight suction electrode at
the cut end of the nerve. Supramaximal brief stimulation (50 V, 0.01 ms)
was given to elicit action potentials. NCV was evaluated by measuring the
distance between the stimulating site and the recording site. The NCV de-
termined from muscle and nerve action potentials coincided, eliminating
the motor endplate as a source of delay. For Tg80.2, the amplitude of
nerve action potentials was reduced relative to control (0.94
 
 6 
 
0.208 [3]
versus 3.03
 
 6 
 
1.353 [3]), but the number of points were too few to show
statistical significance by 
 
t 
 
test (
 
P
 
 
 
z 
 
0.15).
 
Morphological Analysis
 
Hematoxylin and eosin, and ATPase isozyme (pH 4.6 or 9.4) staining of
posterior compartment muscles of the leg was performed according to
standard clinical laboratory protocols. ATPase (pH 9.4) staining con-
firmed the presence of angulated fibers and the absence of fiber type
grouping (not shown).
Routine semi-thin section and electron microscopic analyses of nerve
was performed as described (Quattrini et al., 1996). In most cases, nerves
from three to five animals were evaluated at each time point for each line
of Tg80. When only founders were available, both sciatic as well as femo-
ral nerves were evaluated. To account for variable genetic background in
rescue experiments (performed in FVB/N N(2–5)F1 background), three
to five animals of each genotype were evaluated by four investigators
blinded to the genotype. Each genotype produced a highly reproducible
phenotype.
Quantitation of myelinated fibers in developing motor (quadriceps)
versus sensory (saphenous) branches of femoral nerve was performed as
described (Frei et al., 1999).
The proportion of myelinated fibers in semi-thin section analysis of P28
sciatic nerve (Table I) was estimated by the proportion of axons in a 1:1
relationship with a Schwann cell that also contained myelin, as counted in
three independent transverse sections.
 
Semiquantitative Reverse Transcription
PCR (RT-PCR)
 
Sciatic nerves were dissected from FVB/N, BALB/c (BALB/c Ahn; Har-
lan), transgenic, and nontransgenic littermates and total RNA was pre-
pared as described (Feltri et al., 1999). The RT-PCR assay was performed
as described (Feltri et al., 1999). To verify that the method was quantita-
tive, known amounts (based on RT-PCR analysis for total P
 
0
 
 from each)
of wild-type FVB/N (not containing the DpnII polymorphism) or BALB/c
(containing the DpnII polymorphism) sciatic nerve RT products were
mixed in various proportions, and analyzed as above (see Fig. 7 B). Note
that the polymorphic BglII site (Fig. 1) becomes a DpnII site in the trans-
genic cDNA.
 
Northern Blot Analysis
 
Total
 
 
 
RNA was isolated from mouse sciatic nerves and from various tis-
sues by CsCl
 
2 
 
gradient centrifugation (Chirgwin et al., 1979). Northern
blot analysis was performed as described (Feltri et al., 1999), using cDNAs
of mouse P
 
0
 
, rat MBP, and rat glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) to generate probes.
 
Western Blot Analysis
 
Frozen sciatic nerves dissected from P28 transgenic and nontransgenic lit-
termates were pulverized, sonicated in lysis buffer (95 mM NaCl, 25 mM
Tris-HCl, pH 7.4, 10 mM EDTA, 2% SDS, and protease inhibitors),
boiled for 5 min, and spun at 14,000 rpm in a microcentrifuge for 10 min at
room temperature to eliminate insoluble material. The protein in superna-
tants was determined by BioRad protein assay according to the manufac-
 
Table I. Behavioral, Electrophysiological, and Morphological Phenotype Parallel Tg80 Copy Number and Expression
 
Wild-type Tg80.3 Tg80.4 Tg80.2
 
Copy number 0 2 14 31
Fold overexpression* 0 0.3 0.8 7.3
Median life-span
 
.
 
2 yr
 
.
 
2 yr 10 mo 4 mo
Tremor
 
2 2 11 1111
 
Grip strength
 
‡
 
 (males) 4.7 
 
6
 
 0.28 (10) 5.0 
 
6
 
 0.06 (3) 4.6 
 
6
 
 0.20 (2) 1.4 
 
6
 
 0.14 (3)
 
§
 
Grip strength
 
‡
 
 (females) 5.7 
 
6
 
 0.30 (16) 5.8 
 
6
 
 0.45 (2) 5.0 
 
6
 
 0.01 (2) 1.9 
 
6
 
 0.15 (3)
 
§
 
NCV (m/s) 36 
 
6
 
 4.3 (5) ND 11 
 
6
 
 4.0 (4)
 
§
 
2 
 
6
 
 0.1 (3)
 
§
 
Percent myelinated fibers
 
i
 
100 100 50
 
,
 
10
 
*Age of analyses: expression, tremor, and percent myelinated fibers at P28; grip strength at 
 
z
 
P100; NCV at P42.
 
‡
 
Grip strength 5 absolute grip strength (g)/body weight (g).
§P , 0.01 by t test as compared with wild-type.
iThe percent of axons in 1:1 relationships with Schwann cells that are myelinated.The Journal of Cell Biology, Volume 148, 2000 1024
turer’s instructions. Equal amounts of homogenates (containing 2.5–10 mg
of protein) were brought up to 5 ml with 8 M urea, to which was added 5 ml
of 8 M urea, 0.05 M DTT, 1%SDS in water, followed by 10 ml of standard
reducing sample buffer. The samples were denatured, resolved on a 12%
SDS-polyacrylamide gel, and electroblotted onto PVDF membrane. Pre-
liminary experiments with increasing amounts of wild-type nerve homoge-
nates between 2.5 and 10 mg determined the linear range of dose-response
for each of tubulin, MBP, PMP22, and P0. To verify equal loading of pro-
tein, membranes were stained with amido black or ponceau red. Parallel
blots were blocked with 0.05% Tween, 5% dry milk in PBS, and incubated
with the appropriate antibody in 0.05% Tween and 1% dry milk in PBS.
Mouse mAbs recognized P0 (P07, the generous gift of Dr. Juan Archelos,
Department of Neurology, Karl-Franzens-Universitat, Graz, Austria;
Archelos et al., 1993), MBP (Boehringer Mannheim), PMP22 (the gener-
ous gift of Dr. Ueli Suter, Swiss Federal Institute of Technology, Zürich,
Switzerland), and b-tubulin (Sigma Chemical Co.). Peroxidase-conjugated
secondary antibodies (Sigma Chemical Co.) were visualized using the ECL
method with autoradiography film (Pharmacia Biotech). The intensity of
bands was quantified by densitometry, and the ratio of intensities for each
myelin protein and b-tubulin was determined. Many blots were checked di-
rectly for equal loading by amido black staining after antibody experiments
were completed. Deglycosylation with PNGase F and endoglycosidase H
was performed on homogenates per manufacturer’s instructions (New En-
gland Biolabs). mAb P07 recognized two bands of Mr 28,500 and 22,000–
24,000, as previously noted in rodent nerve by Archelos et al. (1993), who
speculated that the lower band was a degraded form of P0. Deglycosylation
analysis of either transgenic or wild-type P28 nerve lysates showed that
both bands contained a mixture of endoglycosidase H-sensitive and -resis-
tant (immature and mature, respectively) forms of P0, as previously re-
ported by Brunden (1992) for adult nerve.
Because both Northern and Western analysis of sciatic nerves pooled
from ten Tg80.3 or ten normal littermates at P28 underestimated the de-
crease in MBP expression seen by Western analysis performed on pairs of
nerves from single animals, we hypothesized that Tg80.3 animals mani-
fested some combination of incomplete penetrance or variable expressivity
for reduced MBP expression. Western blot analysis for P0 and MBP nor-
malized to tubulin on multiple pairs of nerves confirmed incomplete pene-
trance, as 40% of Tg80.3 animals showed P0 overexpression as compared
with the mean of the normal littermates, and each animal with P0 overex-
pression showed an z50% reduction of MBP (for example, see Fig. 9).
Taqman® Quantitative RT-PCR Analysis
Quantitative RT-PCR was performed as per manufacturer’s instructions
(Taqman®, PE Applied Biosystems Instruments) on an ABI PRISM 7700
sequence detection system (Applied Biosystems Instruments), using total
RNA prepared as above from P28 sciatic nerves. The relative standard
curve method was applied using total RNA from wild-type littermate sci-
atic nerves as the reference. Tg80.3 and wild-type determinations were
carried out in separate tubes for both P0 mRNA and GAPDH mRNA. RT
was performed as above. PCR amplification was performed with input RT
product corresponding to 0.5 ng of starting RNA. PCR conditions were:
508C for 2 min, 958C for 10 min, followed by 958C for 15 s, 608C for 1 min
for 40 cycles in TaqMan® universal master reaction mix. Primers included:
P0 forward, 59-GTCCAGTGAATGGGTCTCAGATG-39; P0 reverse, 59-
CTTGGCATAGTGGAAAATCGAAA-39; GAPDH forward, 59-TGC-
ACCACCAACTGCTTAG-39; and GAPDH reverse, 59-GGATGCAG-
GGATGATGTTC-39. Probes included: P0 FAM-59-ACCTGGCGCTAC-
CAGCCTGAAGG-39-TAMRA; and GAPDH JOE-59-CAGAAGACT-
GTGGATGGCCCCTC-39-TAMRA. This analysis revealed that P0
mRNA was increased 0.68 6 0.27, n 5 3 (mean 6 SEM) in Tg80.3 relative
to wild-type, which agrees reasonably well with 0.3-fold overexpression by
semiquantitative RT-PCR analysis of the level of Tg80.3 mRNA relative
to endogenous P0 mRNA, and 60% overexpression of P0 by Western
analysis.
Results
Extra Copies of Mpz Cause Dysmyelination in 
Peripheral Nerve
To overexpress P0 we employed the mP0TOT transgene
(Tg80), which contains the entire Mpz gene and 6 kb of 59
flanking sequence (Fig. 1). mP0TOT containing the lacZ
reporter gene embedded in Mpz exon 1 was previously
shown to be expressed specifically in myelin-forming
Schwann cells in postnatal peripheral nerve, in parallel
with endogenous Mpz (Feltri et al., 1999). We prepared
transgenic mice by standard techniques and obtained ten
founders. Four manifested wobbling gait and tremor and
were unable to breed. We were able to establish only one
line from these severely affected mice by in vitro fertiliza-
tion from the founder 80.2, and we subsequently main-
tained this line by ovarian transplantation. The remaining
six founders manifested little or no tremor; two of these
transmitted the transgene to progeny (hereafter, F80 de-
notes founder animals, whereas Tg80, animals of a line;
e.g., F80.2 or Tg80.2). Southern blot analysis showed that
copy number ranged from 1 to .40 (Fig. 1).
F80.1, F80.8, F80.9, and Tg80.2 animals (all copy num-
ber .20) showed a severe phenotype including gait diffi-
culty, reduced weight, tremor, atrophy of the paraspinal
and hindlimb musculature (Fig. 2 A), and reduced life-
span (Table I). Nerve conduction velocities in the Tg80.2
animals were profoundly reduced to z2 m/s with temporal
dispersion of the compound motor action potential (Fig. 2
B) suggesting a dysmyelinating neuropathy. Morphologi-
cal analysis of leg muscles showed angulated and atrophic
fibers suggestive of denervation, but no fiber type group-
Figure 2. Phenotype of high copy number Tg80.2 animals. A,
Tg80.2 animals at P120 manifested atrophy in axial and hindlimb
muscles. B, Traces are shown of CMAP generated by sciatic
nerve stimulation in P42 animals. Arrows indicate stimulation ar-
tifact. Note the markedly delayed onset and dispersion of the
Tg80.2 CMAP, due to the slowed NCV. C, ATPase isotype stain-
ing (pH 4.6) in leg muscles revealed atrophy of many fibers and
angulated fibers (arrows), suggesting denervation. Bar, 100 mm.Wrabetz et al. P0 Overexpression Causes Dysmyelination 1025
ing to suggest nerve regeneration. These data were consis-
tent with a severe dysmyelinating neuropathy with second-
ary effects on neurons.
Morphological analysis of high copy number animals
confirmed severe dysmyelination with rare evidence of
myelin destruction. Semi-thin section analysis of P28 sci-
atic nerve from Tg80.2 animals showed remarkable hypo-
myelination and an increase in the number of Schwann
cell nuclei (Fig. 3). Occasional patches of myelinated fi-
bers were seen at P28 (Fig. 3) and more frequently at P42
(data not shown). Electron microscopic analysis of these
nerves showed a mixture of fibers with thin myelin sheaths
for the diameter of axon, and fibers in which single
Schwann cells ensheathed axons, but formed no myelin
(Fig. 4). Within the perineurial compartment, collagen was
increased. There was little evidence of active demyelina-
tion as myelin debris was not seen extracellularly or in
macrophages. Periodicity appeared normal in the few thin
myelin sheaths present (Fig. 4, inset). Nonmyelin-forming
(Remak) Schwann cells with apparently normal ensheath-
ment and segregation of small axons could be found (Fig.
4). No axonal degeneration was observed.
Remarkably, in each transverse section of sciatic nerve
at P28, several families of Schwann cells associated with
bundles of naked axons of mixed caliber were identified
(Fig. 3 C, arrows). Ultrastructural analysis (Fig. 4) re-
vealed that nerve development was arrested at the stage in
which Schwann cells were segregating large axons away
from these bundles. Normally these bundles disappear
from rodent sciatic nerve in the first few days after birth.
Many other large axons were associated with, but only
partially ensheathed by, a single Schwann cell surrounded
by many pockets of redundant basal lamina containing
collagen. Very rarely, single naked axons surrounded by a
basal lamina were seen (data not shown). These data sug-
gested that Schwann cells had incompletely retracted their
processes after segregation of large axons. The unsorted
bundles of axons did not depend on the site of chromo-
somal insertion of Tg80.2, as they were also present in
F80.1 and F80.8, and very rarely in Tg80.4 animals. These
features all suggested a perinatal effect of increased Mpz
gene dosage.
Dysmyelination Results from Developmental Delay
To confirm that the defect in myelination resulted from
developmental delay, and not myelin destruction, we ex-
amined nerves at various postnatal ages. In contrast to
controls, Tg80.2 sciatic nerves at P5 and P14 contained vir-
tually no myelin (Fig. 5). Also, the axon-sorting defect was
more evident at P5 and P14 than at P28 by both semi-thin
section analysis (compare Figs. 5 and 3) and EM (data not
shown). Even in P45 or P90 transgenic nerves some bun-
dles of unsorted larger diameter axons remained (Fig. 5).
To quantitate the lack of myelin formation, we examined
the motor branch (quadriceps) of developing femoral
nerve as previously described (Frei et al., 1999). By P10,
,1% of axons in 1:1 relationships with Schwann cells were
myelinated in Tg80.2 nerve, whereas virtually 100% of
such axons were myelinated in wild-type nerve (Table II).
A very low level of demyelination was detected in quadri-
ceps nerves, as occasional degenerating myelin fragments
could be seen within axons or Schwann cells at P10. Thus,
the abnormal features of P28 nerves resulted primarily
from developmental delay, not from destruction of myelin
that had been synthesized earlier, although some fibers ac-
quired myelin by adulthood.
The occasional thinly myelinated fibers were not distrib-
uted randomly in transverse sections of sciatic nerve. One
possibility was that motor and sensory fibers were differ-
entially affected, since fibers originating from single spinal
roots are also nonrandomly distributed in sciatic nerve
(Ueyama, 1978). Consistent with this idea, the motor
branch (quadriceps) was more dysmyelinated than the
sensory branch (saphenous) of femoral nerve by P10 in
Tg80.2 animals (Table II). In addition, ventral roots were
Figure 3. Semi-thin section analysis
of sciatic nerve in Tg80.2. Trans-
verse (A and C) or longitudinal (B
and D) sections stained with tolui-
dine blue from P28 Tg80.2 (C and
D) as compared with wild-type (A
and B) sciatic nerves showed a
marked paucity of myelin (one in-
ternode of thin myelin is marked by
a double asterisk) and an increased
number of nuclei (arrowheads). In
addition, bundles of unsorted axons
surrounded by several Schwann cell
nuclei were evident in every section
(arrows; see also Fig. 4). No onion
bulbs were seen. Bar, 20 mm.The Journal of Cell Biology, Volume 148, 2000 1026
more markedly dysmyelinated than dorsal roots in both
Tg80.2 (Yin, X., unpublished results) and Tg80.3 homo-
zygotes (see below; Quattrini, A., unpublished results).
Thus, as in several other rodent models (reviewed in Mar-
tini, 1997), motor fibers are relatively more dysmyelinated
than sensory fibers in Tg80 mice.
Dysmyelination Parallels Mpz Dosage
and Overexpression
The increasing severity of the behavioral, electrophysio-
logical, and morphological phenotype paralleled increas-
ing transgene copy number (Table I; Fig. 6). For example,
animals with 0–10 copies (Tg80.3, F80.10) appeared be-
haviorally normal, and had normally myelinated nerves by
P28 (Fig. 6 B). In contrast, animals with 10–20 copies
(Tg80.4 and F80.7) manifested mild tremor, NCV of 11m/s
(Tg80.4), and dysmyelination with z50% of the large ax-
ons ensheathed by single Schwann cells that had not
formed myelin (Fig. 6 C). Finally, animals with .20 cop-
ies (Tg80.2, F80.1, F80.8, and F80.9) manifested evident
tremor, weak grip strength, conduction velocity of 2 m/s
(Tg80.2), and severe hypomyelination along with delayed
axonal sorting (Fig. 6, E and F).
Thus, we performed RT-PCR analysis to confirm that
the severity of phenotype paralleled Mpz overexpression.
Primers that recognized exons 2 and 3 of Mpz, flanking a
polymorphic restriction site in exon 3, allowed us to distin-
guish and quantitate the transgenic relative to endogenous
P0 mRNA. We standardized the assay by analyzing mix-
Figure 4. Ultrastructural analysis of
Tg80.2 sciatic nerve showed dysmy-
elination. A, A typical transverse sec-
tion of P28 sciatic nerve showed a
mixture of occasional Schwann cells
that had formed thin myelin sheaths
of normal periodicity (inset), or more
commonly, Schwann cells that had
ensheathed single large axons, but
had not advanced an inner mesaxon
around them (asterisks). Nonmyelin-
forming Schwann cells (nmsc) en-
sheathed small axons normally. Bar, 5
mm. B, Other Schwann cell families
surrounded bundles of mixed caliber,
naked axons; some of these Schwann
cells were segregating large axons
away from the bundles (arrow). Bar,
2 mm. C, Many Schwann cells were
surrounded by pockets of redundant
basal lamina, some containing col-
lagen fibers (arrowheads). Bar, 1 mm.
Table II. Percent of Myelinated Fibers in Motor and Sensory 
Branches of P10 Femoral Nerve
Tg80.2 Wild-type
%%
Quadriceps ,1 100
Saphenous 5–10 70Wrabetz et al. P0 Overexpression Causes Dysmyelination 1027
tures of known amounts of cDNAs reverse-transcribed
from sciatic nerve mRNA of BALB/c or FVB/N mice, the
strains from which Tg80 or the endogenous Mpz gene de-
rived, respectively. As shown in Fig. 7 B, the assay pro-
duced proportions within 65% of the starting amounts.
Analyzing mRNA from P28 sciatic nerves of Tg80.2,
Tg80.3, or Tg80.4 animals, we found that Mpz was overex-
pressed from 30 to z700%. Overexpression paralleled
copy number, and severity of phenotype, among the cate-
gories of low, medium, and high copy number (Table I).
To show that Mpz was overexpressed shortly after birth,
the point in development at which myelination was de-
layed, we performed RT-PCR analysis on Tg80.2 sciatic
nerves at P2. We found that the ratio of Tg80 to endoge-
nous Mpz was 6.9-fold at P2, very similar to 7.3-fold de-
termined at P28 (Fig. 7 C). This data, taken together with
the demonstration by ultrastructural immunocytochemis-
try that P0 is significantly increased in periaxonal, abax-
onal, and Golgi membranes of arrested Tg80.2 Schwann
cells at P5 (see Figure 3 of Yin et al., 2000, this issue),
shows that P0 overexpression is associated with congenital
hypomyelination in sciatic nerve.
In the mildly affected Tg80.3, dysmyelination was re-
lated to the expression of endogenous Mpz. As Mpz ex-
pression approaches its peak between P15 and P21 (Stahl
et al., 1990), Tg80.3 sciatic nerves were hypomyelinated
(thin sheaths for axon diameter) as compared with control
(data not shown), whereas by P28, when Mpz expression is
falling to adult levels, sciatic nerves contained ultrastruc-
turally normal myelin (Fig. 6 B). Thus, we hypothesized
that total Mpz expression in Tg80.3 sciatic nerves had ex-
ceeded a threshold at P15, above which hypomyelination
results. To directly identify such a threshold, we bred
Tg80.3 to homozygosity. P28 Tg80.3 homozygotes mani-
fested tremor and dysmyelination (Fig. 6 D), whereas P28
80.3 hemizygotes did not (Fig. 6 B). RT-PCR analysis con-
firmed an increase in overexpression from 30% in Tg80.3
Figure 5. Semi-thin section analysis of Tg80.2 sciatic nerves dur-
ing postnatal development. Transverse sections stained with tolu-
idine blue from wild-type (A, C, E, and G) or Tg80.2 (B, D, F,
and H) animals at P5 (A and B), P15 (C and D), P45 (E and F),
and P90 (G and H) demonstrate that dysmyelination was already
present by P5 and remained throughout development. Arrows in-
dicate bundles of unsorted axons. Extracellular myelin debris was
not obvious at any age (see also Fig. 4). Bar, 50 mm.
Figure 6. Dysmyelination parallels Mpz gene dosage. Low mag-
nification electron micrographs of transverse sections of P28 sci-
atic nerve from FVB/N (A), Tg80.3 (B), Tg80.4 (C), Tg80.3 ho-
mozygote (D), Tg80.2 (E), and F80.8 (F) demonstrate that
dysmyelination was absent in low copy number animals (B),
moderate in middle copy number animals (C), and most pro-
nounced in high copy number animals (E and F). Note that in
contrast to Tg80.3 hemizygotes (B), Tg80.3 homozygotes mani-
fested dysmyelination (D). Bar, 5 mm.The Journal of Cell Biology, Volume 148, 2000 1028
hemizygote nerves to 80% in Tg80.3 homozygote nerves
(Fig. 7 C). Of note, the effects of Mpz overexpression
were reproducible between transgenic lines, as the behav-
ioral and morphologic phenotypes of Tg80.3 homozygotes
(80% overexpression) and Tg80.4 animals (80% overex-
pression) were similar (compare Fig. 6, C and D). These
data confirm that the severity of dysmyelination depends
on Mpz dosage.
To further confirm this relationship, and that dysmy-
elination did not depend on ectopic expression or a struc-
tural alteration of Tg80, the converse experiment was per-
formed by breeding Tg80.4 into the Mpz null background.
As compared with Tg80.4 (Fig. 8 B), Tg80.4 in the het-
erozygous null background produced more myelin in sci-
atic nerve, showing a mixture of hyper- and hypomyelin-
ated fibers (Fig. 8 F). When Tg80.4 was bred into the
homozygous null background, myelination returned to es-
sentially normal (Fig. 8 D), consistent with the prediction
that total Mpz expression should decrease from 180% in
Tg80.4 animals to near normal in Tg80.4/homozygous Mpz
null animals. These data demonstrate that a threshold ex-
ists for Mpz overexpression between 30 and 80% (130–
180% total Mpz expression), above which dysmyelination
results. More importantly, in the absence of endogenous
Mpz, Tg80.4 generated P0 sufficient to form normal my-
elin sheaths. Therefore, the overexpression phenotype de-
pends uniquely on dosage of Mpz, not on an ectopic effect
or structural alteration of transgenic P0.
P0 Glycoprotein Is Overexpressed
To determine whether increased dosage of Mpz and ex-
pression of P0 mRNA resulted in overexpression of P0, we
performed Western blot analysis. In Tg80.3 nerves at P28,
where nerves were ultrastructurally normal (Fig. 6 B), P0
was overexpressed by z60% (Fig. 9; 0.6 6 0.16, n 5 5
[mean 6 SEM]), as predicted by the RT-PCR analysis. In-
creased total P0 mRNA was sufficient to explain this in-
crease, as confirmed by Taqman® quantitative RT-PCR
analysis: total P0 mRNA in Tg80.3 sciatic nerves was in-
creased 0.68 6 0.27, n 53. Of note, as Mpz overexpression
rose further, the level of P0 fell, corresponding to more se-
vere dysmyelination: it was slightly less than control in
Tg80.4, and significantly reduced in Tg80.2. Thus, as P0
overexpression exceeds a threshold leading to dysmyelina-
tion, mRNA and protein levels diverge, as protein levels
reflect primarily the bulk quantity of P0 in myelin sheaths.
P0 deriving from the transgene could not be distinguished
from endogenous P0 (including deglycosylation with PNG-
ase F or endoglycosidase H, followed by Western blot
analysis, data not shown) suggesting that the transgenic
protein underwent normal posttranslational modification.
In keeping with this, ultrastructural immunocytochemical
analysis showed that the few myelin sheaths seen in P42
Tg80.2 ventral roots contained 40% more grains for P0 as
compared with control sheaths (see Figure 4 of Yin et al.,
2000, this issue). Thus, at least some of the extra P0 proba-
bly arrived to myelin sheaths.
P0 Overexpression Is Accompanied by Dysregulated 
Expression of other Myelin Genes, even in the Absence 
of Dysmyelination 
To examine for possible effects of P0 overexpression on
the synthesis of other myelin proteins in the presence of
normal myelination or dysmyelination, we performed West-
ern blot analysis on P28 sciatic nerves from animals of low
(Tg80.3), medium (Tg80.4), or high (Tg80.2) copy number.
As for P0, the level of MBP was reduced in association
with the loss of bulk myelin in Tg80.4 and Tg80.2 nerves.
In addition, higher molecular weight isoforms of MBP,
which in the CNS are associated with early myelinogenesis
(Barbarese et al., 1978), were predominant in Tg80.4 and
Tg80.2, consistent with developmental delay, whereas the
18-kD isoform, most abundant in mature CNS myelin
Figure 7. Semiquantitative RT-PCR analysis reveals Mpz over-
expression. A, Total RNA prepared from sciatic nerve was re-
verse-transcribed; the product was amplified by PCR using a
primer pair that recognized identically both endogenous (FVB/N)
or Tg80 (BALB/c) P0 cDNAs. The FVB/N cDNA was distin-
guished by DpnII digestion, revealing 244- and 82-nucleotide (nt)
products. B, Various mixtures of FVB/N (F) and BALB/c (B) re-
verse-transcribed product were analyzed to validate the method.
The relative proportion (in percent of total signal) of FVB/N
(326-nt band) or BALB/c (244 1 82-nt bands) were 6 5% of pre-
dicted in three separate experiments (one shown). C, Reverse-
transcribed products from sciatic nerve total RNA from various
transgenic nerves at P28 or P2 (Tg80.2 P2) were analyzed for the
relative proportion of Tg80 P0 mRNA. Overexpression (-fold)
was the quotient of Tg80 signal divided by endogenous signal.
Note that the pairs, Tg80.4 and Tg80.3H (homozygote) or Tg80.2
P28 and Tg80.2 P2, manifested very similar ratios of overexpres-
sion. Undigested amplification product (uncut) revealed only the
326-nt band.Wrabetz et al. P0 Overexpression Causes Dysmyelination 1029
sheaths, was predominant in Tg80.3 and the control. Sur-
prisingly, the MBP level was reduced by z50% in P28
Tg80.3 sciatic nerves as compared with control (Fig. 9;
0.52 6 0.05, n 5 5), in the absence of myelin abnormality
(Fig. 6 B). PMP22 was also reduced by 35% in Tg80.3
(0.37 6 0.16, n 52), but was equal to, or twofold increased
in Tg80.2 and Tg80.4 nerves, respectively (Fig. 9). The
level of a nonmyelin protein, tubulin, was not altered. P0
overexpression thus perturbed myelin protein levels in not
only the presence, but also the absence of dysmyelination,
where the reduced levels of proteins cannot be explained
by the loss of bulk myelin.
Since P0 accounts for .50% of protein in peripheral my-
elin (Greenfield et al., 1973), and thus represents the bulk
of protein in nerve lysates, overexpression of P0 might arti-
factually cause a reduction in the amount of other proteins
detected in Western blots. For instance, overexpression of
P0 by 60% might be expected to increase total nerve pro-
tein by z30%, and if the expression of other proteins re-
mains unchanged, their proportion of total nerve protein
would be reduced by 25%. To control for this possibility,
amido black staining of blots revealed that proteins other
than P0 or MBP (easily recognized in amido black staining,
see Fig. 9) were equally loaded between Tg80.3 and con-
trol (Fig. 9). Moreover, the reduction in MBP was 50%,
significantly .25%, and therefore, out of proportion to
changes in total protein due to P0 overexpression. Thus,
Schwann cells sense and respond to P0 overexpression by
dysregulating other myelin proteins before exceeding a
threshold for dysmyelination.
Discussion
We have shown that myelinogenesis requires expression
of the P0 within a narrowly defined range. Our data are
most consistent with a model in which overexpressing P0
results in dose-dependent arrest of nerve development,
ranging from transient hypomyelination with mild overex-
pression, to arrest of Schwann cells in a 1:1 relationship
with large axons with moderate overexpression, to inabil-
ity of Schwann cells to segregate axons with the highest
overexpression. This array of phenotypes suggests multi-
ple pathogenetic mechanisms, some acting before and
some during myelin formation. We have identified two
plausible mechanisms: the first involves altered trafficking
of P0 in promyelin-forming Schwann cells (Yin et al., 2000,
this issue), and the second involves abnormal stoichiome-
try in the expression of myelin genes. These studies reveal
new stages in nerve development at which Schwann cells
are susceptible to altered gene dosage and suggest that P0
overexpression represents a new mechanism of hereditary
neuropathy.
Figure 8. Dysmyelination is rescued in the Mpz
null background. Tg80.4 was crossed into the
Mpz heterozygous and homozygous null back-
ground and offspring were identified by South-
ern blotting (G). The Mpz null allele produced a
2.8-kb band due to the BglII polymorphism (see
Fig. 1), and an additional 2.1-kb band due to the
neomycin resistance gene. In the homozygous
null animals, no 6.8-kb band appeared as the en-
dogenous FVB/N Mpz alleles were absent.
Tg80.4 was distinguished (both the Mpz null al-
lele and Tg80.4 contain the BglII polymorphism)
by the presence of a much more intense 1.0-kb
band. Semi-thin section analysis of P28 sciatic nerves from 3–5 animals of each genotype showed that Tg80.4 homozygous null nerves
(80.4/2/2; D) appeared normally myelinated as compared with nontransgenic (FVB/N; A) littermates, and as compared with the dysmy-
elinated Tg80.4 (B) or homozygous null (Mpz2/2; C) littermates. Note that at P28, heterozygous null (Mpz1/2; E) littermates were
slightly hypomyelinated in the FVB/N congenic background, and that Tg80.4 heterozygous null nerves (80.4/1/2; F) showed a mixture of
hypo- and hypermyelinated fibers. Bar, 20 mm.The Journal of Cell Biology, Volume 148, 2000 1030
The phenotypes observed in P0 transgenic mice do not
arise from structural alteration or ectopic expression of
the transgenic protein. First, a version of mP0TOT con-
taining lacZ embedded in exon 1 expressed the reporter
with the same cell-specific and developmental profile as
Mpz (Feltri et al., 1999). Moreover, in the present study,
the ratio of transgenic to endogenous P0 mRNA remained
stable from P2 (Fig. 7) through adulthood (Wrabetz, L., un-
published result). Second, Western blot analysis of multi-
ple independent lines revealed that the transgenic and
endogenous P0 proteins were indistinguishable, even by
deglycosylation analysis. Most importantly, when the P0
transgene (Tg80.4 line) was bred into the homozygous
P0 null background, normal myelination resulted, even
though all P0 was transgenic in origin. The sum of this data
strongly supports the view that the phenotype of P0 trans-
genics derives from increased dosage and expression of
Mpz in Schwann cells.
Schwann Cell Response to P0 Overexpression Is Specific
Dysmyelination might represent a nonspecific response
to glycoprotein overexpression. However, even though
Schwann cell development is arrested by altered dosage of
several genes related to myelination (some encoding gly-
coproteins), specific morphological features distinguish
each phenotype (Mpz, Giese et al., 1992; Pmp22, Adlkofer
et al., 1995; Magyar et al., 1996; Sereda et al., 1996; Huxley
et al., 1998; Oct6, Bermingham et al., 1996; Jaegle et al.,
1996; Krox20, Topilko et al., 1994). In particular, develop-
mental arrest at the stage of sorting large caliber axons
from bundles of naked axons is unique to P0 overex-
pression, suggesting an effect early in nerve development.
The data from Yin et al. (2000, this issue) demonstrate
that even common morphological features belie specific
Schwann cell dysfunction. Schwann cells arrested in a 1:1
relationship with axons in P0 transgenic mice have nar-
rowed mesaxonal spaces, whereas the same cells in PMP22
overexpressor mice do not (compare Figure 6 in Yin et al.,
2000, this issue, to Figure 7 in Huxley et al., 1998). Finally,
we report that mistrafficking of P0 in the P0 transgenic
mice does not disrupt sorting of myelin-associated glyco-
protein into appropriate subcellular compartments (Yin et
al., 2000, this issue), indicating that glycoprotein traffick-
ing is not generally impaired.
Dose Dependence and Mechanisms of
Developmental Arrest
The phenotype resulting from P0 overexpression is dose-
dependent. As copy number and the level of transgenic
mRNA rise, the behavioral and electrophysiological phe-
notype worsen, and the proportion of appropriately myelin-
ated fibers falls (Fig. 6; Table I). Breeding the Tg80.3 line
(30% overexpression) to homozygosity produced dysmy-
elination similar to hemizygous Tg80.4 mice with compa-
rable levels of expression (Fig. 7 C). Conversely, crossing
the Tg80.4 transgene into the homozygous P0 null back-
ground (predicted normalized P0 levels) produced normal
myelination (Fig. 8). These experiments place the thresh-
old for dysmyelination between 30 and 80% P0 overex-
pression. It is important to note that the phenotype of P0
overexpression is one of dysmyelination, not demyelina-
tion. Study of early development in Tg80.4 (not shown)
and Tg80.2 mice (Fig. 5) demonstrates that myelin is never
properly formed in affected fibers, not that myelin is
formed and then destroyed.
As a general rule, as Mpz dosage rises, Schwann cells
are progressively impaired. Thus, we observed three cate-
gories of abnormal Schwann cells in P0 overexpressor
nerves: 1, Schwann cells that formed thin myelin; 2,
Schwann cells arrested after having ensheathed a large
axon and advanced a mesaxon; and 3, Schwann cells ar-
rested as they attempted to sort axons. Nerves with low
P0 overexpression (e.g., Tg80.3) have only the first type
of Schwann cells; nerves with moderate overexpression
(e.g., Tg80.4) have primarily the first and second type of
Schwann cells; nerves with highest overexpression (e.g.,
Tg80.2) have all three types.
It is important to note that our quantitation of P0 over-
expression is at the level of whole nerve, whereas the
heterogeneity of phenotypes in individual cells suggests
variation in either the level of transgene expression or sus-
ceptibility to dysmyelination. Interestingly, we observed
that motor nerves and ventral roots were more severely af-
fected than sensory nerves and dorsal roots in the P0 trans-
genics. In fact, semiquantitative in situ hybridization anal-
ysis for P0 mRNA on teased fibers from sciatic nerves
shows that Schwann cells associated with larger fibers ex-
press more P0 (Griffiths et al., 1989). Perhaps motor fibers,
which are larger than sensory fibers on the average, have a
stronger stimulus to express both endogenous and trans-
genic P0, and therefore more quickly achieve levels of P0
overexpression sufficient to arrest Schwann cell develop-
ment. Similarly increased susceptibility of Schwann cells
associated with motor axons to dysmyelination has been
observed with mutations or dosage alterations of Pmp22,
Mpz, Mag, and Cx32 (Martini, 1997).
More than one mechanism may account for these
Schwann cell abnormalities in P0 overexpressor nerves.
Figure 9. P0 overexpression is
accompanied by alteration of
other myelin protein levels.
Western blot analysis was per-
formed on P28 sciatic nerve ly-
sates from Tg80 animals with
dysmyelination ranging from
none (Tg80.3), to moderate
(Tg80.4), to severe (Tg80.2).
Dysmyelination was associated
with proportionally decreased
total P0, and high molecular
weight isoforms of MBP consis-
tent with developmental delay.
In contrast, Tg80.3 nerves
showed  z60% increased P0 and
mature MBP isoforms. Note
that MBP and PMP22 levels
were reduced in Tg80.3 nerves,
even when normalized to tubu-
lin or amido black staining of
the blot for total protein. Num-
bers 3 1,000 indicate approxi-
mate  Mr.Wrabetz et al. P0 Overexpression Causes Dysmyelination 1031
For example, nerves of the Tg80.3 line at P28, with ultra-
structurally normal myelin, manifest a 50% increase of P0
protein in combination with reduced levels of two other
myelin proteins, MBP and PMP22. Preliminary analysis
suggests that these alterations are reflected in part by
changes in mRNA levels (Wrabetz, L., and M.L. Feltri,
unpublished observation). We propose that the Schwann
cell response to P0 overexpression further dysregulates the
stoichiometry of myelin proteins (MBP and PMP22 are re-
quired for normal peripheral nerve myelination; Adlkofer
et al., 1995; Gould et al., 1995; Martini et al., 1995), leading
to reversible hypomyelination at the peak of P0 gene ex-
pression in the third week after birth, and recovery as P0
expression falls to adult levels. Parallel morphological and
expression analysis throughout Tg80.3 nerve development
will be required to test this hypothesis.
In contrast, the Schwann cells that are arrested at the
stage of 1:1 relationships with axons deliver P0 to atypical
membrane locations. In Yin et al. (2000, this issue), we
show that mistargeting of P0 to the membranes of the ad-
vancing mesaxon activates obligate P0 homophilic adhe-
sion, arresting spiral wrapping and myelination.
Finally, many Schwann cells in the severely affected
mice are unable to properly sort mixed caliber axons in
spinal roots and nerves. P0 was detected in these Schwann
cells by immunocytochemistry (Yin et al., 2000, this issue).
This sorting defect likely arises from P0 overexpression
rather than ectopic expression, as both P0 mRNA and pro-
tein also have been detected in normal late embryonic
nerves, when Schwann cell sorting of axons normally be-
gins (Lee et al., 1997). Qualitative analysis of Schwann cell
number (Fig. 3) and internuclear distance (Yin et al., 2000,
this issue) in the severely affected nerves suggest that
there is no defect in Schwann cell proliferation or survival,
a conclusion that is also supported by BrdU-labeling indi-
ces (Yin, X., and B.D. Trapp, unpublished observation).
This is in contrast to ErbB3 null mice, in which sciatic
nerves contain bundles of unsorted axons due to a marked
reduction in the number of Schwann cells (Riethmacher et
al., 1997). Alternatively, as an adhesion molecule, P0 may
interfere with Schwann cell migration or elongation. In
dystrophic (dy/dy) mice with laminin 2 deficiency, spinal
nerves also contain bundles of naked, mixed caliber axons,
hypothesized to be due to a Schwann cell migration defect
(Madrid et al., 1975). Further studies of the cell growth and
the molecular phenotype of the P0 transgenic Schwann
cells are underway to distinguish these possibilities.
P0 Gene Dosage and Stoichiometry
Mutations in both P0 and PMP22 result in similar dysmy-
elinating phenotypes, suggesting common functions. Re-
cently, D’Urso et al. (1999) have provided biochemical ev-
idence for physical interaction between P0 and PMP22,
suggesting the possibility of multiprotein assemblies in
myelin. Determination of the crystal structure of the P0 ex-
tracellular domain suggests that P0 could interact with
itself in compact myelin to form a planar crystal with reg-
ular spaces (Shapiro et al., 1996). Such spaces could poten-
tially accommodate PMP22 (D’Urso et al., 1999) and de-
fine a fixed ratio between P0 and PMP22 content. As noted
above, the threshold of overexpression (80%) is remark-
ably similar for both P0 (present study) and PMP22 (Hux-
ley et al., 1998), a result that could be interpreted in terms
of a fixed stoichiometry in their assembly. One prediction
of such a model is that overexpression of one partner pro-
tein may perturb assembly through trans-dominant nega-
tive interactions with the other (e.g., sequestration or al-
tering geometric interactions). Paradoxically, therefore,
matching of the expression of partner proteins to comply
with stoichiometric requirements may rescue dysmyelina-
tion, for example by crossing appropriate P0- and PMP22-
overexpressing mice. Such paradoxical rescue has been
observed in CNS myelin when the shiverer phenotype (ab-
sence of MBP) was improved by reducing PLP dosage
(Stoffel et al., 1997).
Implications for Hereditary Neuropathies
Increased dosage of PMP22 and PLP causes both rodent
and human myelinopathies (CMT1A and Pelizeaus-Merz-
bacher Disease, respectively), and 80% overexpression of
Mpz causes neuropathy in mice. Could altered dosage of
MPZ cause human neuropathy? Partial trisomies of hu-
man chromosome 1 that include the MPZ locus 1q22 are
rare and produce complex phenotypes; one such case in-
cluded equinovarus alterations of the feet and contrac-
tures of the extremities, which suggest, but do not prove,
peripheral neuropathy (Chen et al., 1994). Also, P0 mis-
sense mutations are associated with the human demyelin-
ating neuropathies CMT1B, Déjérine Sottas syndrome,
and congenital hypomyelination neuropathy (CHN; War-
ner et al., 1996). Of note, profoundly reduced nerve con-
duction velocities (1–2 m/s), the paucity of active myelin
destruction or onion bulbs, and the redundant basement
membrane formation (Fig. 4 C) in P0 overexpressor mice
resemble CHN (Harati and Butler, 1985). In addition,
low level P0 overexpression produces transient hypomy-
elination in mice, similar to a subset of reversible CHN
(Ghamdi et al., 1997; Levy et al., 1997). Finally, mutations
in the Krox 20 transcription factor, encoded by EGR2, are
also associated with CHN. Since one of these EGR2 muta-
tions likely disinhibits Krox 20 (Warner et al., 1998), and
Krox 20 may regulate P0 expression (Topilko et al., 1994;
Zorick et al., 1999), it is possible that MPZ overexpression
contributes to the pathogenesis of this EGR2 mutation.
The present study advises caution for treatment of
CMT1B neuropathies in which the MPZ mutation pre-
dicts loss of P0 expression, and for which replacement gene
therapy might therefore be considered (Shy et al., 1995;
Guenard et al., 1999). Such therapy may require excep-
tionally precise regulation of P0 expression in human
nerve, as only 60% overexpression in mice results in im-
paired myelin formation.
Finally, Tg80.2 animals develop atrophy and morpho-
logic changes in skeletal muscle, and a trend towards re-
duced nerve action potential amplitude, that together
suggest axonal pathology. Axonal degeneration was not
observed in studies of proximal nerves or lumbar ventral
roots, but is prominent in intramuscular nerve branches
(Yin, X., and B.D. Trapp, unpublished observations). It is
well established from mouse models that primary defects
in Schwann cells can lead to secondary changes in axonal
properties (de Waegh et al., 1992; Yin et al., 1998), includ-The Journal of Cell Biology, Volume 148, 2000 1032
ing in distal nerves where axons might even be prone to
degenerate (Frei et al., 1999; Sancho et al., 1999). Simi-
larly, hereditary demyelinating neuropathies in man mani-
fest important axonal effects, more prominent distally,
which account for significant disability. Thus, mice overex-
pressing P0 may provide another useful model for studying
the pathogenesis of axonal damage as a consequence of
primary Schwann cell dysfunction.
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